Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02860091 · ClinicalTrials.gov registry record
Blood Ropivacaine Concentrations Following Chest Wall Nerve Block Continuous Infusion
A clinical trial of Pain, Postoperative, sponsored by Boston Children's Hospital.
- Active
- Registry status
- 26
- Enrollment target
- 1
- Study location
NCT02860091: Active study of Pain, Postoperative, sponsored by Boston Children's Hospital.
NCT02860091 is a study of Pain, Postoperative that is active but no longer recruiting, run by Boston Children's Hospital. The registered enrollment target is 26 participants, below the 273-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02860091, a study of Pain, Postoperative, is active but no longer recruiting, sponsored by Boston Children's Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
The main objective of this proposed investigation is to evaluate blood ropivacaine concentrations in infants and toddlers following the initiation of, and over the course of, continuous paravertebral nerve blockade using ropivacaine infusion for postoperative pain control following esophageal atresia repair procedures that include posterior tracheopexy. Continuous unilateral chest wall nerve blockade (CUCWNB) using ropivacaine is the current standard of practice for this surgical population at the investigators' institution and, as such, this study does not aim to alter the current standard clinical care received by participants but rather evaluate the blood concentrations of ropivacaine as it is routinely used.
Primary Outcome
Plasma ropivacaine concentration
Conditions Studied
Interventions
- DRUG Ropivacaine infusion
Study Locations (1)
Massachusetts
- Boston Children"S Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2024-12 |
What the registry record for NCT02860091 still lists
NCT02860091 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 273-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 1 intervention - of which Ropivacaine infusion is the first listed.
NCT02860091 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT02860091 about?
NCT02860091 is a clinical study titled "Blood Ropivacaine Concentrations Following Chest Wall Nerve Block Continuous Infusion". The main objective of this proposed investigation is to evaluate blood ropivacaine concentrations in infants and toddlers following the initiation of, and over the course of, continuous paravertebral nerve blockade using ropivacaine infusion for postoperative pain control following esophageal atresi...
What is the current status of trial NCT02860091?
This trial is currently active not recruiting. The enrollment target is 26 participants. The study started on 2018-10-01. Estimated completion is 2024-12.
What conditions does trial NCT02860091 study?
This clinical trial studies the following conditions: Pain, Postoperative.
What interventions are being tested in trial NCT02860091?
The interventions under investigation include: Ropivacaine infusion (DRUG).
Who is sponsoring clinical trial NCT02860091?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02860091 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain, Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02860091's enrollment target sits among peer trials
26 107th of 113 higher than 7 of 113 other Pain, Postoperative trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Randomized Control Trial, Cryoablation as an Adjunct to Surgical Stabilization of Rib Fractures
RECRUITING · NA
-
Lumbar Steroid Use in Patients Undergoing Posterior Lumbar Decompression
RECRUITING · Phase 3
-
Management of Postoperative Discomfort in Young Children Following Dental Rehabilitation Under General Anesthesia
RECRUITING · Phase 4
-
Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery
RECRUITING · Phase 4
-
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
RECRUITING · Phase 4
-
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI